Convergence Partners was formed in 2018 by experienced venture capital and operational experts with a vision to establish a venture capital firm that actively supports the internationalisation and market access of European technology innovators to large Asian markets, with a particular focus on China and India. Whereas our current investment focus is on EU HealthTech startups, Convergence is able to open its established EU-Asia cross-border acceleration platform to any Deeptech company that is keen to realise the enormous Asia market potential.
Please get in touch with us to discuss your growth and investment plans.
The Convergence Team is represented in Switzerland and Germany and has additional hubs in Shenzhen, Hangzhou and Singapore to effectively support the internationalization of our portfolio companies. The investment team is supported by experienced venture partners, a top-class advisory board and leading landing & scale-up partners in Europe and Asia.